The online version of this article (https://doi.org/10.1186/s12890-018-0587-7) contains supplementary material, which is available to authorized users.
Chronic obstructive pulmonary disease (COPD) is one of the most common comorbidities in community acquired pneumonia (CAP) patients. We aimed to investigate the characteristics and mortality risk factors of COPD patients hospitalized with CAP.
A retrospective cohort study was conducted at Shanghai Pulmonary Hospital and Shanghai Dahua Hospital. Clinical and demographic data in patients diagnosed with CAP were collected between January 2015 and June 2016. Logistic regression analysis was performed to screen mortality risk factors of COPD patients hospitalized with CAP.
Of the total 520 CAP patients, 230 (44.2%) patients had been diagnosed comorbid with COPD (COPD-CAP). CAP patients comorbid with COPD patients had higher rate of need for ICU admission (18.3% vs 13.1%) and need for NIMV (26.1% vs 1.4%) than without COPD (nCOPD-CAP). The PSI, CURB-65 and APACHE-II scores in COPD-CAP patients were higher than that in nCOPD-CAP patients (95 vs 79, P < 0.001; 1 vs 1, P < 0.001; 13 vs 8, P < 0.001, respectively). Logistic regression analysis indicated that aspiration, D-dimer > 2.0 μg/mL and CURB-65 ≥ 3 were risk factors associated with in-hospital mortality ((odd ratio) OR = 5.678, OR = 4.268, OR = 20.764, respectively) in COPD-CAP patients. The risk factors associated with 60-day mortality in COPD-CAP patients were comorbid with coronary heart disease, aspiration, need for NIMV (non-invasive mechanical ventilation) and CURB-65 ≥ 3 (OR = 5.206, OR = 7.921, OR = 3.974, OR = 18.002, respectively).
COPD patients hospitalized with CAP had higher rate of need for NIMV, need for ICU admission and severity scores than those without COPD. Aspiration, D-dimer > 2.0 μg/mL, comorbid with coronary heart disease, need for NIMV and CURB-65 ≥ 3 were mortality risk factors in CAP patients comorbid with COPD.
Additional file 1: Figure S1. Computing processes of Youden index. The optimal Sensitivity and Specificity of each ROC curve are highlighted. (TIFF 3568 kb)12890_2018_587_MOESM1_ESM.tif
Additional file 2: Table S1. Arterial blood gas analysis of COPD-CAP patients in stable stage and on admission. (DOC 31 kb)12890_2018_587_MOESM2_ESM.doc
Additional file 3: Table S2. Logistic regression analyses of the risk factors associated with in-hospital mortality in CAP patients without COPD. (DOC 37 kb)12890_2018_587_MOESM3_ESM.doc
Additional file 4: Table S3. Logistic regression analyses of the risk factors associated with 60-day mortality in CAP patients without COPD. (DOC 38 kb)12890_2018_587_MOESM4_ESM.doc
Additional file 5: Figure S2. ROC curves for the PSI, CURB-65 and APACHE-II to predict primary outcomes in CAP patients with COPD. (A) ROC curves for the PSI, CURB-65 and APACHE-II to predict in-hospital mortality in CAP patients with COPD. (B) ROC curves for the PSI, CURB-65 and APACHE-II to predict 60-day mortality in CAP patients with COPD. ROC curve, receiver operating characteristic curve; AUC, area under the curve; Se, Sensitivity; Sp, Specificity; CI, confidence interval. (TIFF 881 kb)12890_2018_587_MOESM5_ESM.tif
Additional file 6: Figure S3. ROC curves for the PSI, CURB-65 and APACHE-II to predict secondary outcomes in CAP patients with COPD. (A) ROC curves for the PSI, CURB-65 and APACHE-II to predict need for ICU admission in CAP patients with COPD. (B) ROC curves for the PSI, CURB-65 and APACHE-II to predict need for NIMV in CAP patients with COPD. ROC curve, receiver operating characteristic curve; ICU, intensive care unit; NIMV, non-invasive mechanical ventilation AUC, area under the curve; Se, Sensitivity; Sp, Specificity; CI, confidence interval. (TIFF 901 kb)12890_2018_587_MOESM6_ESM.tif
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72. https://doi.org/10.1086/511159. CrossRefPubMed
Daniel P, Woodhead M, Welham S, McKeever TM, Lim WS. Mortality reduction in adult community-acquired pneumonia in the UK (2009–2014): results from the British Thoracic Society audit programme. Thorax. 2016;71(11):1061–3. https://doi.org/10.1136/thoraxjnl-2016-208937. CrossRefPubMed
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65. https://doi.org/10.1164/rccm.201204-0596PP. CrossRefPubMed
Yin P, Wang H, Vos T, Li Y, Liu S, Liu Y, et al. A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013: findings from the global burden of disease study 2013. Chest. 2016;150(6):1269–80. https://doi.org/10.1016/j.chest.2016.08.1474. CrossRefPubMed
Ryan M, Suaya JA, Chapman JD, Stason WB, Shepard DS, Thomas CP. Incidence and cost of pneumonia in older adults with COPD in the United States. PLoS One. 2013;8(10):e75887. https://doi.org/10.1371/journal.pone.0075887. CrossRefPubMedPubMedCentral
Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. 2006;28(2):346–51. https://doi.org/10.1183/09031936.06.00131905. CrossRefPubMed
British Thoracic Society Standards of Care C. Non-invasive ventilation in acute respiratory failure. Thorax. 2002;57(3):192–211. CrossRef
Molinos L, Clemente MG, Miranda B, Alvarez C, del Busto B, Cocina BR, et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Inf Secur. 2009;58(6):417–24. https://doi.org/10.1016/j.jinf.2009.03.003.
Falguera M, Martin M, Ruiz-Gonzalez A, Pifarre R, Garcia M. Community-acquired pneumonia as the initial manifestation of serious underlying diseases. Am J Med. 2005;118(4):378–83. https://doi.org/10.1016/j.amjmed.2005.01.011. CrossRefPubMed
Pifarre R, Falguera M, Vicente-de-Vera C, Nogues A. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med. 2007;101(10):2139–44. https://doi.org/10.1016/j.rmed.2007.05.011. CrossRefPubMed
Gomez-Junyent J, Garcia-Vidal C, Viasus D, Millat-Martinez P, Simonetti A, Santos MS, et al. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. PLoS One. 2014;9(8):e105854. https://doi.org/10.1371/journal.pone.0105854. CrossRefPubMedPubMedCentral
Cilli A, Erdem H, Karakurt Z, Turkan H, Yazicioglu-Mocin O, Adiguzel N, et al. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality. J Crit Care. 2013;28(6):975–9. https://doi.org/10.1016/j.jcrc.2013.08.004. CrossRefPubMed
Clayton NA, Carnaby GD, Peters MJ, Ing AJ. Impaired laryngopharyngeal sensitivity in patients with COPD: the association with swallow function. Int J Speech Lang Pathol. 2014;16(6):615–23. https://doi.org/10.3109/17549507.2014.882987. CrossRefPubMed
Yamauchi Y, Yasunaga H, Matsui H, Hasegawa W, Jo T, Takami K, et al. Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2015;15:69. https://doi.org/10.1186/s12890-015-0064-5. CrossRefPubMedPubMedCentral
Taylor JK, Fleming GB, Singanayagam A, Hill AT, Chalmers JD. Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort. Am J Med. 2013;126(11):995–1001. https://doi.org/10.1016/j.amjmed.2013.07.012. CrossRefPubMed
Hayashi M, Iwasaki T, Yamazaki Y, Takayasu H, Tateno H, Tazawa S, et al. Clinical features and outcomes of aspiration pneumonia compared with non-aspiration pneumonia: a retrospective cohort study. J Infect Chemother. 2014;20(7):436–42. https://doi.org/10.1016/j.jiac.2014.04.002. CrossRefPubMed
Arslan S, Ugurlu S, Bulut G, Akkurt I. The association between plasma D-dimer levels and community-acquired pneumonia. Clinics (Sao Paulo). 2010;65(6):593–7. https://doi.org/10.1590/S1807-59322010000600006. CrossRef
Nastasijevic Borovac D, Radjenovic Petkovic T, Pejcic T, Stankovic I, Jankovic I, Ciric Z, et al. Role of D-dimer in predicting mortality in patients with community-acquired pneumonia. Med Glas (Zenica). 2014;11(1):37–43.
Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012;125(6):773–81. https://doi.org/10.1161/CIRCULATIONAHA.111.040766. CrossRefPubMed
Confalonieri M, Potena A, Carbone G, Porta RD, Tolley EA, Umberto MG. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1585–91. https://doi.org/10.1164/ajrccm.160.5.9903015. CrossRefPubMed
Rello J, Rodriguez A, Torres A, Roig J, Sole-Violan J, Garnacho-Montero J, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J. 2006;27(6):1210–6. https://doi.org/10.1183/09031936.06.00139305. CrossRefPubMed
Xiao K, Su LX, Han BC, Yan P, Yuan N, Deng J, et al. Analysis of the severity and prognosis assessment of aged patients with community-acquired pneumonia: a retrospective study. J Thorac Dis. 2013;5(5):626–33. https://doi.org/10.3978/j.issn.2072-1439.2013.09.10. PubMedPubMedCentral
Richards G, Levy H, Laterre PF, Feldman C, Woodward B, Bates BM, et al. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS. J Intensive Care Med. 2011;26(1):34–40. https://doi.org/10.1177/0885066610383949. CrossRefPubMed
- The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II